BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Pfizer
Pfizer
AstraZeneca
National Institutes of Health Clinical Center (CC)
University of Southern California
Trishula Therapeutics, Inc.
Hummingbird Bioscience
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Shanghai Jiao Tong University School of Medicine
Canadian Cancer Trials Group
Seagen Inc.
Roswell Park Cancer Institute
Eli Lilly and Company
Novartis
Bayer
Bristol-Myers Squibb
Eli Lilly and Company
Gilead Sciences
Incyte Corporation
Celgene
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Northwestern University
EMD Serono
Sanofi
Altor BioScience
NewVac LLC
Washington University School of Medicine
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
Debiopharm International SA
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)